ACTIVATING PYRUVATE KINASE R
The disclosure provides novel chemical compounds useful as activators of PKR. PKR activating compounds are useful in the treatment of disease and disorders associated with modulation of PKR and/or PKM2, such as pyruvate kinase deficiency (PKD).
Saved in:
Main Authors | , , , , , , , , |
---|---|
Format | Patent |
Language | English French German |
Published |
03.07.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The disclosure provides novel chemical compounds useful as activators of PKR. PKR activating compounds are useful in the treatment of disease and disorders associated with modulation of PKR and/or PKM2, such as pyruvate kinase deficiency (PKD). |
---|---|
Bibliography: | Application Number: EP20190862479 |